Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Paul Versage

Physician Assistant Virginia Beach, VA Physician Assistant

NPI 1760409114 CMS profile 11224017

1849 Old Donation Pkwy, Virginia Beach, VA 23454

Open in the dashboard

General payments

$1,126

34 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Paul Versage of Virginia Beach, VA is reported in the CMS Open Payments database as having received $1,126 across 34 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 70th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $129 6
2024 General $335 5
2023 General $180 4
2022 General $281 10
2021 General $200 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Paul Versage
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Paul Versage were reported at $129. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Paul Versage Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $200 $132 $37–$438 $132
2022 $281 $155 $48–$522 $149
2023 $180 $167 $52–$557 $160
2024 $335 $178 $55–$600 $164
2025 $129 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Bioventus LLC $399 8 payments
  2. Abbott Laboratories $146 5 payments
  3. Pacira Pharmaceuticals Incorporated $124 1 payment
  4. Stryker Corporation $72 3 payments
  5. Electronic Waveform Lab, Inc. $72 1 payment
  6. Fidia Pharma USA Inc. $71 4 payments
  7. Vertex Pharmaceuticals Incorporated $65 3 payments
  8. SI-BONE, Inc. $47 2 payments
  9. Avanos Medical $29 2 payments
  10. ConvaTec Inc. $25 1 payment
  11. Other $75 4 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $1,126 34 payments
Products named General payments · program years 2021–2025
  1. EXOGEN ULTRASOUND BONE HEALING SYSTEM $177 3 payments
  2. DUROLANE $142 1 payment
  3. Iovera $124 1 payment
  4. HYMOVIS $71 4 payments
  5. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $40 2 payments
  6. PROCLAIM Structural Heart $39 2 payments
  7. PROCLAIM Neuromodulation $38 1 payment
  8. Axium Sheath Braided DRG $36 1 payment
  9. Mepilex Border Post-Op $36 2 payments
  10. Axium INS DRG IPG $33 1 payment
  11. Other $238 12 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 15 drugs

Part D claims

815

Median for Physician Assistant: 241

Drug cost

$3,936

Median for Physician Assistant: $4,110

Branded share of claims

7.5%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 117 $818
Diclofenac Sodium Generic 63 $640
Meloxicam Generic 263 $502
Celecoxib Generic 29 $480
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 35 $306
Ondansetron Hcl Generic 94 $277
Acetaminophen-Codeine Acetaminophen With Codeine Brand 15 $148
Ibuprofen Generic 27 $140
Ondansetron Odt Ondansetron Brand 11 $124
Prednisone Generic 38 $111

The 10 drugs with the highest cost, of 15 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 43 billing codes

Paid by Medicare

$91,446

Of which drugs: $50,349

Medicare patients

241

Average age 76

Services billed

5,213

162 women, 79 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 27%
Ischemic heart disease 26%
Diabetes 22%
Chronic kidney disease 22%
Atrial fibrillation 20%
Osteoporosis 20%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg J7322 Office 43 2,616 $35,380
Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose J7324 Office 25 138 $13,302
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 113 1,552 $1,130

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

34 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record